Company Cell MedX Corp OTC Bulletin Board
Equities
US15115X1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-15 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
03-12 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58.8
%
| 0 | 60.6 % | 0 | 58.8 % | -55.85% |
eBalance Devices
41.2
%
| 0 | 39.4 % | 0 | 41.2 % | -52.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -54.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 14-11-23 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 14-11-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 297,236,373 | 60,447,694 ( 20.34 %) | 0 | 20.34 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+21.76% | 47.9B | |
+46.62% | 41.42B | |
-2.18% | 40.7B | |
-6.20% | 28.92B | |
+10.19% | 25.55B | |
-20.87% | 19.27B | |
-0.32% | 12.15B | |
+31.04% | 12.14B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- CMXC Stock
- Stock
- Company Cell MedX Corp